Skip Navigation



Glycobiology Advance Access published online on May 19, 2007

Glycobiology, doi:10.1093/glycob/cwm054
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
17/8/805    most recent
cwm054v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Jackson, C. L.
Right arrow Articles by Mohnen, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jackson, C. L.
Right arrow Articles by Mohnen, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

Pectin induces apoptosis in human prostate cancer cells: correlation of apoptotic function with pectin structure

Crystal L. Jackson2, Tina M. Dreaden2, Lisa K. Theobald2, Nhien M. Tran2, Tiffany L. Beal2, Manal Eid3, Mu Yun Gao2, Robert B. Shirley3, Mark T. Stoffel2, M. Vijay Kumar3 and Debra Mohnen1,2

2 Complex Carbohydrate Research Center and Department of Biochemistry and Molecular Biology, The University of Georgia, Athens, GA 30602
3 Medical College of Georgia and VA Medical Center, Augusta, GA 30912


1 To whom correspondence should be addressed; Debra Mohnen Complex Carbohydrate Research Center The University of Georgia 315 Riverbend Rd. Athens, GA 30602-4712 Tel. 706 542-4458Fax. 706-542-4412e-mail: dmohnen{at}ccrc.uga.edu

Received on September 26, 2006; revised on May 9, 2007; accepted on May 10, 2007

Treatment options for androgen-independent prostate cancer cells are limited. Therefore, it is critical to identify agents that induce death of both androgen-responsive and androgen-insensitive cells. Here we demonstrate that a product of plant cell walls, pectin, is capable of inducing apoptosis in androgen-responsive (LNCaP) and androgen-independent (LNCaP C4-2) human prostate cancer cells. Commercially available fractionated pectin powder (FPP) induced apoptosis (approximately 40-fold above non-treated cells) in both cell lines as determined by the Apoptosense assay and activation of caspase-3 and its substrate, poly(ADP-ribose) polymerase. Conversely, citrus pectin (CP) and the pH-modified CP, PectaSol, had little or no apoptotic activity. Glycosyl residue composition and linkage analyses revealed no significant differences between the pectins. Mild base treatment to remove ester linkages destroyed FPP's apoptotic activity and yielded homogalacturonan oligosaccharides. Treatment of FPP with pectin methylesterase to remove galacturonosyl carboxymethylesters and/or with endopolygalacturonase to cleave non-methylesterified homogalacturonan caused no major reduction in apoptotic activity, implicating the requirement for a base-sensitive linkage other than the carboxymethylester. Heat treatment of CP led to the induction of significant levels of apoptosis comparable to FPP, suggesting a means for generating apoptotic pectic structures. These results indicate that specific structural elements within pectin are responsible for the apoptotic activity, and that this structure can be generated, or enriched for, by heat treatment of CP. These findings provide the foundation for mechanistic studies of pectin apoptotic activity and a basis for the development of pectin-based pharmaceuticals, nutraceuticals, or recommended diet changes aimed at combating prostate cancer occurrence and progression.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.